69 results
8-K
EX-10.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal
8-K
EX-99.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
to satisfaction of customary closing conditions. The Company believes that together with these proceeds, the Company’s current cash, cash equivalents … . Such statements include, but are not limited to, statements related to the timing and completion of the offering, the satisfaction of customary closing
8-K
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
Letter is expected to occur on or about November 14, 2023 (the “Closing Date”), subject to satisfaction of customary closing conditions. The Company
8-K
EX-4.1
ycbjsfpq49ehh3v mpz
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
424B5
jnxnuet lpl
25 Oct 22
Prospectus supplement for primary offering
9:39pm
8-K
EX-1.1
cx51dtyy2aq9
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-4.1
yp21sp9
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-99.1
713sa
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
424B5
tyc3oy9s
19 Aug 22
Prospectus supplement for primary offering
8:42am